Sulfachloropyrazine Sodium Global Buyers List: Comprehensive Market Guide for Suppliers and Exporters

Sulfachloropyrazine Sodium (CAS 102-65-8) is a sulfonamide antibiotic widely used in veterinary medicine as an anticoccidial and antibacterial agent. As global livestock production intensifies and demand for animal protein rises, the market for this API continues to expand, creating significant opportunities for manufacturers, exporters, and suppliers.

This comprehensive guide provides insights into the global Sulfachloropyrazine Sodium buyers landscape, regional market dynamics, key players, and actionable strategies to connect with potential buyers worldwide.


Understanding Sulfachloropyrazine Sodium

Sulfachloropyrazine Sodium belongs to the sulfonamide class of antibiotics and exhibits broad-spectrum antimicrobial activity against both Gram-positive and Gram-negative bacteria. The sodium salt form enhances solubility, making it suitable for oral and injectable formulations.

Primary Applications:

  • Treatment of coccidiosis in poultry and rabbits
  • Prevention and management of respiratory and intestinal bacterial infections
  • Treatment of swine dysentery, pasteurellosis, and other bacterial infections in livestock
  • Formulation in medicated feeds, water-soluble powders, and injectable products

Global Market Overview

The global Sulfachloropyridazine Sodium API market was valued at approximately US$73.0 million in 2024 and is projected to reach US$104 million by 2031, with a compound annual growth rate (CAGR) of 5.1%. Global production reached approximately 4,295 tons in 2024, with an average market price of around US$17 per kilogram.

The sulfachloropyrazine sodium market is projected to reach 95-105 million USD by 2025, with estimated CAGR ranging from 3% to 4.5% through 2030.

Key Market Drivers:

  • Expanding global livestock production, particularly in developing regions
  • Intensive farming systems requiring effective disease management solutions
  • Growing demand for animal protein in emerging economies
  • Established regulatory approvals across major livestock-producing countries

Regional Buyers Analysis

Asia-Pacific: The Dominant Market

Asia Pacific dominates the Sulfachloropyrazine Sodium market with estimated growth rates of 4%-5%. This region represents both the largest production center and consumption market.

Key Buyer Countries:

  • China: The world’s largest producer and consumer, with manufacturers like Zhejiang Chemsyn Pharm maintaining approximately 800 tons annual production capacity
  • India: Growing consumption supported by expanding poultry and livestock sectors
  • Southeast Asia: Thailand, Vietnam, and Indonesia contribute through intensive production systems and endemic disease pressures

North America: Moderate Growth with Regulatory Oversight

North America exhibits moderate growth of 2.5%-3.5%. The market faces dual dynamics of established livestock industries balanced against stringent regulatory frameworks.

Key Considerations for Buyers:

  • The US FDA’s Veterinary Feed Directive classifies sulfachloropyridazine sodium as a medically important antimicrobial requiring veterinarian approval
  • Sustained livestock production in swine and poultry sectors maintains base demand levels

Europe: Stringent Regulatory Environment

Europe demonstrates slower growth of 2%-3%, reflecting the most stringent regulatory environment for veterinary antimicrobials globally.

Key Buyer Countries:

  • Germany, France, Spain, and Poland maintain significant livestock production
  • The EU’s ban on prophylactic antibiotic use (effective 2022) creates constrained but ongoing demand for therapeutic applications

Key Manufacturers and Suppliers

Understanding the supply side is essential for identifying buyers, as many manufacturers also serve as distributors and exporters. Major manufacturers include:

CompanyRegionNotes
Zhejiang Chemsyn PharmChina~800 tons annual capacity
Wugan PharmaceuticalChinaKey API producer
Jiangsu Tianhe PharmaceuticalChinaMajor manufacturer
Nanyang Tianhua PharmaceuticalChinaSignificant producer
Zhengzhou Fuyuan Animal PharmaceuticalChinaActive in animal health
Hebei Anlin PharmaceuticalChinaKey industry player
OfichemNetherlandsEuropean supplier
Anhui Sinotech IndustrialChinaUSDMF, CEP/COS certified

These manufacturers often maintain direct relationships with veterinary pharmaceutical companies, formulation manufacturers, and distribution partners worldwide.


How to Identify and Connect with Global Buyers

1. Leverage Industry Databases and Platforms

Platforms like PharmaCompass offer comprehensive lists of Sodium Sulfachloropyrazine Monohydrate API manufacturers, exporters, and distributors, sortable by GMP, USDMF, JDMF, KDMF, CEP (COS), and other certifications.

2. Target Veterinary Pharmaceutical Manufacturers

The primary buyers are veterinary pharmaceutical companies that formulate medicated feeds, water-soluble powders, and injectable products. Focus on regions with intensive livestock production.

3. Monitor Regulatory Approvals

Buyers often seek suppliers with established regulatory certifications. Manufacturers with USDMF, CEP/COS, and GMP compliance are preferred.

4. Utilize Market Research Reports

Comprehensive reports provide detailed buyer intelligence, including:

  • Regional demand lists by application
  • Key players sales lists and market share
  • Import and export data by country

5. Attend Industry Trade Shows and Conferences

Veterinary pharmaceutical trade shows and animal health industry events provide direct access to decision-makers and purchasing managers.


Product Specifications Buyers Look For

When sourcing Sulfachloropyrazine Sodium, buyers typically evaluate:

SpecificationDetail
Purity≥98% or ≥99%
CAS Number102-65-8 (anhydrous) / 1392129-96-2 (monohydrate)
FormPowder, soluble powder (30% formulations available)
CertificationsGMP, USDMF, CEP/COS, JDMF, KDMF
PackagingCustomizable per buyer requirements

Market Trends and Future Outlook

Increasing Demand in Emerging Markets

Growing middle-class populations in Asia and other emerging economies drive meat consumption, supporting sustained veterinary antibiotic requirements.

Regulatory Evolution

While regulatory frameworks addressing antimicrobial resistance may constrain growth in developed markets, therapeutic usage maintains ongoing demand.

Supply Chain Considerations

Recent tariff adjustments and international strategic countermeasures pose volatility risks to global markets, making diversified buyer networks essential.


CÔNG TY TNHH HÓA CHẤT NAVY
NETFARMA ILAC VE PREMIKS SANAYI LIMITED SIRKETI
CÔNG TY TNHH ĐẦU TƯ PHÁT TRIỂN HẢI ĐĂNG
CÔNG TY CỔ PHẦN THÀNH NHƠN
ERNEJOYSON COMPANY LIMITED
VIMAR GIDA TARIM VE HAYVANCILIK SANAYI TICARET ANONIM SIRKETI
GLS GLOBAL LAB SOLUTIONS PRIVATE LIMITED
UNICHEMIE INTERNATIONAL PRIVATE LIMITED
CHROMATOPAK ANALYTICAL INSTRUMENTATION INDIA PVT
CÔNG TY TNHH EMIVEST FEEDMILL VIỆT NAM CHI NHÁNH SẢN XUẤT THUỐC THÚ Y
CÔNG TY TNHH LVA VIỆT NAM
CÔNG TY TNHH THUỐC THÚ Y NĂM THÁI
ELANCO INDIA PRIVATE LIMITED
PRIX PHARMACEUTICA PRIVATE LIMITED
PRIX PHARMACEUTICA PVT LTD
PROGRESSIVE LABORATORIES
CÔNG TY TNHH MTV THUỐC THÚ Y VÀ CHẾ PHẨM SINH HỌC VEMEDIM
CÔNG TY TNHH THƯƠNG MẠI QUỐC TẾ VHL
NAAFCO PHARMA LTD
NAUTIC LOGISTICS
CÔNG TY CỔ PHẦN XUẤT NHẬP KHẨU CAN VN
CÔNG TY CỔ PHẦN XUẤT NHẬP KHẨU DƯỢC MẶT TRỜI
CÔNG TY TNHH VẬT TƯ KHOA HỌC CÔNG NGHỆ T T
ESKAYEF PHARMACEUTICALS LIMITED
FARMCHEMIE PVT LTD
FARMERS CENTRE LIMITED
FJ WEGON ANIMAL HEALTH AND
GLOBAL LAB SOLUTIONS
HILTON PHARMA PVT LTD
KUEHNE NAGEL EOOD
MITLOG HAVA DENIZ TASIMACILIK HIZ A
NINGBO UNIMED PHILIPPINES INC
REDACHEM INGREDIENTS PHILS INC
ULTRAVETS E A LIMITED

Conclusion

The global Sulfachloropyrazine Sodium market offers substantial opportunities for suppliers and exporters. Asia Pacific remains the dominant market, with China serving as both the largest production center and consumption market. North America and Europe, while facing stricter regulatory environments, maintain steady demand through therapeutic applications.

To successfully connect with global buyers, suppliers should leverage industry databases, target veterinary pharmaceutical manufacturers, maintain regulatory certifications, and stay informed about regional market dynamics. With the market projected to reach US$104 million by 2031, strategic positioning in this growing sector can yield significant returns.

error: Content is protected !!